Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study for the PanCystPro Assay in the Management of Pancreatic Cystic Lesions
Sponsor: Amplified Sciences Inc
Summary
The purpose of this research is to learn if the PanCystPro assay can help doctors in making decisions about treatment and monitoring of pancreatic cysts. The PanCystPro test measures glucose, carcinoembryonic antigen (CEA), and gastricsin biomarkers on fluid obtained from a pancreatic cyst. The test reports if the cyst fluid should be considered "Non-mucinous" or "Mucinous". Mucinous pancreatic cysts are more likely to progress to cancer while non-mucinous cysts seldom progress to cancer.
Official title: Clinical Utility Study to Determine Impact of PanCystPro Assay on Physician Decision-making in the Management of Pancreatic Cystic Lesions
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
50
Start Date
2026-02-17
Completion Date
2027-06-30
Last Updated
2026-03-16
Healthy Volunteers
No
Conditions
Locations (3)
Indiana University
Indianapolis, Indiana, United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Rutgers Health
New Brunswick, New Jersey, United States